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Supplementary table 3: Clinical characteristics and survival rates by era of presentation. 
 
 
 
  1980-1989  
(n=11) 
1990-1999 
(n=117) 
2000-2009 
(n=254) 
2010-2017 
(n=305) 
P 
value  
Gender Male 6 (55%) 67 (57%) 161 (63%) 200 (66%) + 
0.412 
Syndrome Idiopathic/
non-
syndromic 
5 (45%) 88 (75%) 157 (62%) 183 (60%) + 
0.025 
RASopathy 4 (36%) 19 (16%) 48 (19%) 55 (18%) 
Friedreich 
ataxia 
1 (10%) 9 (8%) 26 (10%) 23 (8%) 
Inborn 
error of 
metabolism 
1 (10%) 1 (1%) 21 (8%) 41 (13%) 
Length of follow up in 
years (median, IQR) 
15  
(12.6-24) 
11.8  
(6.5 - 18) 
8.5 (5.25-
11.2) 
2.6 (1.3 - 4.1)  
Mortality rate (per 100 
person years at risk) 
2.27 
(0.852 - 6.05) 
1.38 (0.890-
2.14) 
1.71 (0.123-
2.373) 
2.54     
(1.672 - 
3.858)  
* 
0.735 
  
  1980-1989  
(n=11) 
1990-1999 
(n=117) 
2000-2009 
(n=254) 
2010-2017 
(n=305) 
P 
value  
SCD rate (per 100 
person years at risk) 
1.13  
(0.284 - 4.537) 
1.17  
(0.729 - 
1.886) 
1.14  
(0.765-
1.703) 
1.73  
(1.044 - 
2.872) 
* 
0.876 
 
Data expressed as number (%).  Total number of patients is 687 unless otherwise stated. + Indicates 
comparisons were made using Chi square test. * Indicates comparison made using Log Rank Test. 
SCD = sudden cardiac death 
 
 
 
 
 
 
 
 
 
 
 
 
 
